Future endeavors should more effectively reconcile the patient's inherent ischemic susceptibility with the projected escalated peril of hemorrhage. Moreover, further investigation is essential to elucidate the risks and advantages of divergent DPI approaches beyond rivaroxaban and aspirin.

Elegant English: Enhancing Medical Trial Design

原文地址: https://www.cveoy.top/t/topic/lHWE 著作权归作者所有。请勿转载和采集!

免费AI点我,无需注册和登录